Mathematical Model of Influenza Infection Suggests JAK-STAT Activity Drives Severe Pathologies in Juvenile Mice

Lauren L Luciani1, Lauren M Nichols1, Brydie R Huckestein2,3

  • 1Department of Chemical & Petroleum Engineering, University of Pittsburgh, Pittsburgh, PA.

Frontiers in Applied Mathematics and Statistics
|February 25, 2026
PubMed

Insights

Juvenile influenza infection causes severe disease due to heightened inflammation, not viral load. Mathematical modeling suggests higher JAK-STAT activator production in children drives this response, potentially improving antiviral therapy effectiveness.

Area of Science:

  • Immunology
  • Computational Biology
  • Pediatric Infectious Diseases

Background:

  • Children face severe influenza, with inflammation, not immune immaturity, implicated in lung injury.
  • Understanding age-specific immune responses is crucial for pediatric influenza treatment.

Purpose of the Study:

  • To identify age-specific immune mechanisms contributing to severe influenza in juvenile mice.
  • To investigate the role of the JAK-STAT pathway in age-related influenza severity.

Main Methods:

  • Developed an ordinary differential equation (ODE) model of the innate immune response to influenza.
  • Utilized Bayesian statistics and Monte Carlo methods for parameter estimation and model selection.
  • Analyzed age-specific murine lung immune data and computational model scenarios.

Main Results:

  • Identified age-specific differences in the production rate of JAK-STAT pathway activators (e.g., type I IFNs, IL-6).
  • Found higher JAK-STAT activator production in juvenile mice compared to adults.
  • Simulations suggest antiviral therapeutics may be more effective in juvenile populations.

Conclusions:

  • Age-specific production of JAK-STAT activators, like IFN and IL-6, may drive increased inflammation and lung injury in juvenile influenza.
  • Inflammatory responses, rather than viral replication, are key to understanding severe pediatric influenza.
  • Findings support the potential for enhanced efficacy of antiviral therapies in children.